๐Ÿซ Section 448.3 ยท Granulomatous Lung Disease

Nelson Textbook of Pediatrics 22nd Edition | Granulomatosis with polyangiitis (GPA, Wegener): c-ANCA (PR3), cavitary nodules, sinusitis, glomerulonephritis. Sarcoidosis: noncaseating granulomas, BAL CD4/CD8 >4, bilateral hilar lymphadenopathy, erythema nodosum. Berylliosis: chronic beryllium disease, BeLPT positive. GLILD: granulomatous and lymphocytic interstitial lung disease in CVID. Diagnosis: HRCT, ANCA, ACE, BeLPT, lung biopsy. Treatment: corticosteroids, cyclophosphamide/rituximab for GPA, antigen avoidance for berylliosis.

๐ŸŒ paeds.online โ€” Pakistan's Pediatric Platform

๐Ÿ“‹ 30 Clinical Scenarios โ€” Granulomatous Lung Disease

๐Ÿ“‡ Highโ€‘Yield Cards: Granulomatous Lung Disease (Chap 448.3)

๐Ÿฉบ Interactive Clinical Approach: Granulomatous Lung Disease

Select a presentation for diagnostic and management approach.

๐Ÿ“‹ Stepwise Management of Granulomatous Lung Disease

    DiseaseKey Diagnostic FindingTreatment
    Granulomatosis with polyangiitis (GPA)c-ANCA (PR3) in 90%, cavitary nodules, glomerulonephritisCyclophosphamide or rituximab + corticosteroids (induction); methotrexate or azathioprine (maintenance)
    SarcoidosisBAL CD4/CD8 >4, noncaseating granulomas, elevated ACECorticosteroids for progressive lung disease, ocular disease, hypercalcemia
    Berylliosis (Chronic beryllium disease)History of beryllium exposure, BeLPT positiveAntigen avoidance, corticosteroids
    GLILD (with CVID)CVID + granulomas + lymphocytic interstitial pneumoniaIVIG, corticosteroids, rituximab, azathioprine

    โšก Reflex Prompts โ€” Granulomatous Lung Disease Recognition

    ๐Ÿ“– Summary: Granulomatous Lung Disease โ€” Nelson 22nd Ed